Skip to main content

Table 3 Adverse events of the patients between groups

From: Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

 

Early treatment group

Later treatment group

χ2

P value

Hypothyroidism

9 (13.85%)

1 (3.23%)

1.53

0.217

Liver dysfunction

2 (3.08%)

0 (0.00%)

 

1.000*

Spinal deformities

15 (23.08%)

6 (19.35%)

0.17

0.680

  1. *Fisher's precision probability test
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172